Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

0 structures for Q5UQU2

Entry ID Method Resolution Chain Position Source

No variants for Q5UQU2

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q5UQU2

No associated diseases with Q5UQU2

2 regional properties for Q5UQU2

Type Name Position InterPro Accession
domain Helicase/UvrB, N-terminal 100 - 254 IPR006935
domain Helicase superfamily 1/2, ATP-binding domain 78 - 288 IPR014001

Functions

Description
EC Number 3.6.4.13 Acting on ATP; involved in cellular and subcellular movement
Subcellular Localization
  • Virion
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
virion component Any constituent part of a virion, a complete fully infectious extracellular virus particle.

4 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
ATP hydrolysis activity Catalysis of the reaction: ATP + H2O = ADP + H+ phosphate. ATP hydrolysis is used in some reactions as an energy source, for example to catalyze a reaction or drive transport against a concentration gradient.
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
RNA helicase activity Unwinding of an RNA helix, driven by ATP hydrolysis.

No GO annotations of biological process

Name Definition
No GO annotations for biological process

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MNRRNRSNDL NPEPSIENPN NQIAEEFPGN NSVYKSDGYV DLKNNGRLFP IWILKNFKQY
70 80 90 100 110 120
KLPEIIRKEN EDPCNVQVKL ELRKYQEFVG QYLNPQGPYT SILLYHGLGS GKTASAINLM
130 140 150 160 170 180
NILYNYDNGT NFIVLIKASL HNDPWMQDLK EWLGRDPSEQ NVDNVTKLDR YKNIHFVHYD
190 200 210 220 230 240
SPFADSSFMS VIKTLDLSKP TMYIIDEAHN FIRNVYSNIN SKLGKRAKVI YEYIMKDKRE
250 260 270 280 290 300
NKNTRIVLIS ATPAINTPFE LALMFNLLRP GIFPSSELDF NRTFVTESSY PILNPMKKNM
310 320 330 340 350 360
FERRILGLVS YYIGATPDLY ARQELKYINL PMSAYQYDIY RIFEKLEAEI QERARRRGKQ
370 380 390 400 410 420
SQLYRTYTRQ ACNFVFPYVN MNVNGELRPR PGKFRLSEKL ADDFSKGKNL DVPDTEKEIL
430 440 450 460 470 480
NKYTKAIENY LNETERYFQN INKKDAENGR TIINDLDEFK KGFGTKFNSF LQYYQSEGPR
490 500 510 520 530 540
SSLLTEMYNC SPKMLAIAFM TYISPGKVMI YSNYVVMEGI DVMKIYFRLI GFNDFTIARE
550 560 570 580 590 600
YMGYCEYHGR IDPKDRVRIK NMFNDKNNVY GNKCKVIMLS PSATEGIQLL DIRQEHIMEP
610 620 630 640 650 660
YWTEVRIQQV IGRGVRQCSH RDLPMSERIV DIYRYKVIKP ENLDPDDTVR QSTDEYVEDQ
670 680 690 700 710 720
AKSKANLIES FLGAMKEAAV DCELFKEHNM MSQSYYCFKF PESAVTKTNV GPAYREDIKD
730 740 750 760 770 780
DVKYDSGLNS KNSIVERIRV VKVNAVYQIN TDNNNPVYSS PTKYWYNKKT GMVYDFETHY
790 800 810
PVGQVEFIDN LPNKLDKDTY IMRIDVIIPS ITGSVNT